# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-20-016227
Filing Date
2020-08-03
Accepted
2020-08-03 08:33:18
Documents
34
Period of Report
2020-08-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | gnpx20200731_8k.htm | 8-K | 22840
2 | EXHIBIT 99.1 | ex_196385.htm | EX-99.1 | 19241
3 |  | a01.jpg | GRAPHIC | 29898
4 |  | a02.jpg | GRAPHIC | 107142
5 |  | a03.jpg | GRAPHIC | 37439
6 |  | a04.jpg | GRAPHIC | 56715
7 |  | a05.jpg | GRAPHIC | 42929
8 |  | a06.jpg | GRAPHIC | 39093
9 |  | a07.jpg | GRAPHIC | 51871
10 |  | a08.jpg | GRAPHIC | 45632
11 |  | a09.jpg | GRAPHIC | 55230
12 |  | a10.jpg | GRAPHIC | 28917
13 |  | a11.jpg | GRAPHIC | 58187
14 |  | a12.jpg | GRAPHIC | 45992
15 |  | a13.jpg | GRAPHIC | 38612
16 |  | a14.jpg | GRAPHIC | 53528
17 |  | a15.jpg | GRAPHIC | 42954
18 |  | a16.jpg | GRAPHIC | 48162
19 |  | a17.jpg | GRAPHIC | 37887
20 |  | a18.jpg | GRAPHIC | 44654
21 |  | a19.jpg | GRAPHIC | 55843
22 |  | a20.jpg | GRAPHIC | 54501
23 |  | a21.jpg | GRAPHIC | 48754
24 |  | a22.jpg | GRAPHIC | 71170
25 |  | a23.jpg | GRAPHIC | 29373
26 |  | a24.jpg | GRAPHIC | 51631
27 |  | a25.jpg | GRAPHIC | 67100
28 |  | a26.jpg | GRAPHIC | 55584
29 |  | a27.jpg | GRAPHIC | 48429
30 |  | a28.jpg | GRAPHIC | 48688
31 |  | a29.jpg | GRAPHIC | 54453
32 |  | a30.jpg | GRAPHIC | 56791
33 |  | a31.jpg | GRAPHIC | 34256
34 |  | a32.jpg | GRAPHIC | 24611
| Complete submission text file | 0001437749-20-016227.txt |  | 2198117

Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 201067972
SIC: 2834 Pharmaceutical Preparations